PARP inhibitors in ovarian cancer: overcoming resistance with combination strategies

por Miller, Rowan E, El-Shakankery, Karim H, Lee, Jung-Yun
Publicado 2022

Ovarian Cancer Therapy: Homologous Recombination Deficiency as a Predictive Biomarker of Response to PARP Inhibitors

por Miller, Rowan E, Elyashiv, Osnat, El-Shakankery, Karim H, Ledermann, Jonathan A
Publicado 2022

Ratio of Oxygen Saturation Index to Guide Management of COVID-19 Pneumonia

por Fink, Douglas L., Goldman, Nina R., Cai, James, El-Shakankery, Karim H., Sismey, George E., Gupta-Wright, Ankur, Tai, Charlotte X.
Publicado 2021